BioTransform will recruit 11 enthusiastic, talented and driven doctoral candidates (DCs), highly motivated to become interdisciplinary and competent researchers and professionals in the area of health and food science. All recruited fellows will be enrolled in a PhD degree programme and will be employed full-time in this interdisciplinary and intersectoral network.
- DC1 – UAntwerp (Antwerp, Belgium): Tracking differences in gastrointestinal metabolism of bilberry bioactives between healthy/normal weight and prediabetic individuals through the in vitro gastrointestinal simulation model GIDM-colon (applications open 1/12/25 – 31/1/26)
- DC2 – UAntwerp (Antwerp, Belgium): Tracking differences in gastrointestinal metabolism of olive oil biophenols between healthy/normal weight and prediabetic/obese individuals through the in vitro gastrointestinal simulation model GIDM-colon (applications open 1/12/25 – 31/1/26)
- DC3 – NKUA (Athens, Greece): A blinded placebo-controlled human pilot study for the investigation of the role of bilberry and olive bioactives on oxidative stress parameters and inflammatory markers – Relevance in a South-European population (applications open 1/10/25 – 30/11/25)
- DC4 – NKUA (Athens, Greece): Exploration of metabolism pathways of olive biophenols using UPLC-HRMS/MS profiling and metabolomics approaches (applications open 1/10/25 – 30/11/25)
- DC5 – MedUniGraz (Graz, Austria): A blinded placebo-controlled human pilot study for the investigation of the role of bilberry and olive bioactives on oxidative stress parameters and inflammatory markers – Relevance in a Central-European population (applications open 1/10/25 – 30/11/25)
- DC6 – UGraz (Graz, Austria): Exploration of metabolism pathways and bioactives’ metabolites from bilberries by using UPLC-HRMS approaches (applications open 1/10/25 – 30/11/25)
- DC7 – Teagasc, UCC (Cork, Ireland): Impact of bilberry and olive bioactives on gut microbiome (applications open 1/12/25 – 31/1/26)
- DC8 – RSU (Riga, Latvia): In vitro microsomal metabolism of dialysates produced in the GIDM-Colon and activity of metabolites (applications open 1/2/26 – 31/3/26)
- DC9 – UBath (Bath, UK): Exploration of olive and bilberry bioactives bioavalability aspects through advanced in silico techniques (applications open 1/2/26 – 31/3/26)
- DC10 – ICL (London, UK): Correlation studies between spectrometric, spectroscopic, biochemical, and microbiome sequencing data after intake of bilberry and olive bioactives (applications open 1/2/26 – 31/3/26)
- DC11 – LIOS (Riga, Latvia): Synthesis of potentially bioactive metabolites for chemical structure revision, analytical quantification and bioactivity studies (applications open 1/12/25 – 31/1/26)